Related Experiment Video
Updated: Sep 29, 2025

10:46
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
10.8K
SARS-CoV-2 triggered relapse of multiple sclerosis.
1Neurology & Neurophysiology Center, Vienna, Austria.
Clinical Neurology and Neurosurgery
|March 19, 2022
Summary
A mild COVID-19 infection in a patient with relapsing remitting multiple sclerosis (RRMS) triggered a disease relapse, indicating a potential link between SARS-CoV-2 and neuro-immunological exacerbations. Neurologists should monitor patients for such events post-infection.
Area of Science:
- Neuroscience
- Immunology
- Infectious Diseases
Background:
- Emerging evidence suggests SARS-CoV-2 may precipitate new or relapsing neuro-immunological conditions.
- Multiple Sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
Observation:
- A 27-year-old female with relapsing-remitting MS (RRMS) on disease-modifying therapy (DMT) experienced a relapse two weeks after a mild COVID-19 infection.
- Imaging revealed increased thoracic spine lesion load and a new enhancing lesion, indicating active disease progression.
Findings:
- The patient's RRMS exacerbated following SARS-CoV-2 infection, despite being on DMT.
- Treatment with steroids and a change in DMT led to clinical improvement.
- The patient tolerated SARS-CoV-2 vaccination six months post-infection.
Implications:
- SARS-CoV-2 infection may lead to MS exacerbation and potential DMT failure.
- A causal relationship between SARS-CoV-2 and MS relapse is plausible.
- Clinicians must maintain vigilance for neuro-immunological disease activity after SARS-CoV-2 infection.
More Related Videos
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
5.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.5K
Autoimmune Disorders
715
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
715
Single Nucleotide Polymorphisms-SNPs
16.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
16.1K
Viral Recombination
23.9K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.9K

